{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:07:05Z","timestamp":1755907625370,"version":"3.44.0"},"reference-count":19,"publisher":"SMC Media","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>We report the case of a 62-year-old male patient fully vaccinated for COVID-19, admitted to our emergency room for persistent fever associated with exertional dyspnoea, skin lesions, diffuse myalgias and arthralgias not responsive to broad-spectrum antibiotic and antiviral therapy, who developed a rapidly progressive refractory to treatment interstitial lung disease due to anti-melanoma differentiation-associated gene 5 (MDA5) antibodies, that required mechanical ventilation and ECMO. Here, we highlight the importance of always considering alternative diagnoses, i.e. viral and autoimmune diseases, including anti-MDA5 antibody screening, when dealing with patients with a skin rash, seronegative polyarthralgias and interstitial pneumonia, or acute respiratory distress syndrome of unknown origin.<\/jats:p>","DOI":"10.12890\/2021_002860","type":"journal-article","created":{"date-parts":[[2021,10,18]],"date-time":"2021-10-18T14:22:58Z","timestamp":1634566978000},"source":"Crossref","is-referenced-by-count":1,"title":["Skin Rash and Interstitial Pneumonia Can Be a Fatal Combination: A Rare Case of Anti-Melanoma Differentiation-Associated Gene 5 (MDA5)-Associated Interstitial Lung Disease"],"prefix":"10.12890","volume":"8","author":[{"given":"Giorgia","family":"Borio","sequence":"additional","affiliation":[{"name":"Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Terracciano","sequence":"additional","affiliation":[{"name":"Neurology Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federico","family":"Buttafava","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, IRCCS San Matteo di Pavia, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Vercelli","sequence":"additional","affiliation":[{"name":"Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Pagani","sequence":"additional","affiliation":[{"name":"Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Zanzani","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Manicardi","sequence":"additional","affiliation":[{"name":"Intensive Care Unit, Guglielmo da Saliceto Hospital, Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Magnacavallo","sequence":"additional","affiliation":[{"name":"Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erika","family":"Poggiali","sequence":"additional","affiliation":[{"name":"Emergency Department, Guglielmo da Saliceto Hospital, Piacenza, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10397","published-online":{"date-parts":[[2021,10,18]]},"reference":[{"key":"10.12890\/2021_002860_ref1","doi-asserted-by":"crossref","unstructured":"<li>Sato S, Hoshino K, Satoh T, Fujita T, Kawakami Y, Fujita T, et al. RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: association with rapidly progressive interstitial lung disease. <em>Arthritis Rheum<\/em> 2009;<strong>60<\/strong>:2193\u20132200.<\/li>","DOI":"10.1002\/art.24621"},{"key":"10.12890\/2021_002860_ref2","doi-asserted-by":"crossref","unstructured":"<li>Gupta R, Kumar S, Gow P, Hsien-Cheng Chang L, Yen L. Anti-MDA5-associated dermatomyositis. <em>Intern Med J<\/em> 2020;<strong>50<\/strong>(4):484\u2013487.<\/li>","DOI":"10.1111\/imj.14789"},{"key":"10.12890\/2021_002860_ref3","doi-asserted-by":"crossref","unstructured":"<li>Allenbach Y, Uzunhan Y, Toquet S, Leroux G, Gallay L, Marquet A, et al. Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: study of 121 cases. <em>Neurology<\/em> 2020;<strong>95<\/strong>(1):e70\u2013e78.<\/li>","DOI":"10.1212\/WNL.0000000000009727"},{"key":"10.12890\/2021_002860_ref4","doi-asserted-by":"crossref","unstructured":"<li>Mehta P, Machado PM, Gupta L. Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry. <em>Rheumatol Int<\/em> 2021;<strong>41<\/strong>(6):1021\u20131036.<\/li>","DOI":"10.1007\/s00296-021-04819-1"},{"key":"10.12890\/2021_002860_ref5","doi-asserted-by":"crossref","unstructured":"<li>Hamaguchi Y, Kuwana M, Hoshino K, Hasegawa M, Kaji K, Matsushita T, et al. Clinical correlations with dermatomyositis-specific autoantibodies in adult Japanese patients with dermatomyositis: a multicenter cross-sectional study. <em>Arch Dermatol<\/em> 2011;<strong>147<\/strong>:391\u2013398.","DOI":"10.1001\/archdermatol.2011.52"},{"key":"10.12890\/2021_002860_ref6","doi-asserted-by":"crossref","unstructured":"<li>Kurtzman DJB, Vleugels RA. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features.<em> J Am Acad Dermatol<\/em> 2018;<strong>78<\/strong>(4):776\u2013785.<\/li>","DOI":"10.1016\/j.jaad.2017.12.010"},{"key":"10.12890\/2021_002860_ref7","doi-asserted-by":"crossref","unstructured":"<li>Benveniste O, Stenzel W, Allenbach Y. Advances in serological diagnostics of inflammatory myopathies. <em>Curr Opin Neurol<\/em> 2016;<strong>29<\/strong>:662\u2013673.<\/li>","DOI":"10.1097\/WCO.0000000000000376"},{"key":"10.12890\/2021_002860_ref8","doi-asserted-by":"crossref","unstructured":"<li>Gupta L, Muhammed H, Naveen R, Kharbanda R, Gangadharan H, Misra D, et al. Insights into the knowledge, attitude and practices for the treatment of idiopathic inflammatory myopathy from a cross-sectional cohort survey of physicians. <em>Rheumatol Int<\/em> 2020;<strong>40<\/strong>(12):2047\u20132055.<\/li>","DOI":"10.1007\/s00296-020-04695-1"},{"key":"10.12890\/2021_002860_ref9","unstructured":"<li>Tokiyama K, Tagawa H, Yokota E, Nagasawa K, Kusaba T, Tsuda Y, et al. [Two cases of amyopathic dermatomyositis with fatal rapidly progressive interstitial pneumonitis]. <em>Ryumachi<\/em> 1990;30(3):204\u2013209; discussion 209\u2013211. <\/li>"},{"key":"10.12890\/2021_002860_ref10","doi-asserted-by":"crossref","unstructured":"<li>Tsuji H, Nakashima R, Hosono Y, Imura Y, Yagita M, Yoshifuji H, et al. Multicenter prospective study of the efficacy and safety of combined immunosuppressive therapy with high-dose glucocorticoid, tacrolimus, and cyclophosphamide in interstitial lung diseases accompanied by anti-melanoma differentiation-associated gene 5-positive dermatomyositis. <em>Arthritis Rheumatol<\/em> 2020;<strong>72<\/strong>(3):488\u2013498. <\/li>","DOI":"10.1002\/art.41105"},{"key":"10.12890\/2021_002860_ref11","doi-asserted-by":"crossref","unstructured":"<li>Shirakashi M, Nakashima R, Tsuji H, Tanizawa K, Handa T, Hosono Y, et al. Efficacy of plasma exchange in anti-MDA5-positive dermatomyositis with interstitial lung disease under combined immunosuppressive treatment. <em>Rheumatology (Oxford)<\/em> 2020;<strong>59<\/strong>(11):3284\u20133292. <\/li>","DOI":"10.1093\/rheumatology\/keaa123"},{"key":"10.12890\/2021_002860_ref12","doi-asserted-by":"crossref","unstructured":"<li>Mrosak J, Banasiak K, Edelheit B, Lapin C, Tory H, Collins M. Polymyxin-B hemoperfusion as a novel treatment for rapidly progressive interstitial lung disease in a pediatric patient diagnosed with anti-MDA5 juvenile dermatomyositis. <em>J Clin Rheumatol<\/em>. Epub 2019 Nov 15. doi: 10.1097\/RHU.0000000000001191. <\/li>","DOI":"10.1097\/RHU.0000000000001191"},{"key":"10.12890\/2021_002860_ref13","doi-asserted-by":"crossref","unstructured":"<li>Hayashi M, Aoki A, Asakawa K, Sakagami T, Kikuchi T, Takada T. Cytokine profiles of amyopathic dermatomyositis with interstitial lung diseases treated with mycophenolate. <em>Respirol Case Rep<\/em> 2017;<strong>5<\/strong>(4):e00235.<\/li>","DOI":"10.1002\/rcr2.235"},{"key":"10.12890\/2021_002860_ref14","doi-asserted-by":"crossref","unstructured":"<li>Mao MM, Xia S, Guo BP, Qian WP, Zheng ZX, Peng XM, et al. Ultra-low dose rituximab as add-on therapy in anti-MDA5-positive patients with polymyositis\/dermatomyositis associated ILD. <em>Respir Med<\/em> 2020;<strong>172<\/strong>:105983. <\/li>","DOI":"10.1016\/j.rmed.2020.105983"},{"key":"10.12890\/2021_002860_ref15","doi-asserted-by":"crossref","unstructured":"<li>Ye S, Chen XX, Lu XY, Wu MF, Deng Y, Huang WQ, et al. Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study. <em>Clin Rheumatol<\/em> 2007;<strong>26<\/strong>:1647\u20131654.<\/li>","DOI":"10.1007\/s10067-007-0562-9"},{"key":"10.12890\/2021_002860_ref16","doi-asserted-by":"crossref","unstructured":"<li>Kurasawa K, Arai S, Namiki Y, Tanaka A, Takamura Y, Owada T, et al. Tofacitinib for refractory interstitial lung diseases in anti-melanoma differentiation-associated 5 gene antibody-positive dermatomyositis. <em>Rheumatology (Oxford)<\/em> 2018;<strong>57<\/strong>:2114\u20132119.<\/li>","DOI":"10.1093\/rheumatology\/key188"},{"key":"10.12890\/2021_002860_ref17","doi-asserted-by":"crossref","unstructured":"<li>Chen Z, Wang X, Ye S. Tofacitinib in amyopathic dermatomyositis-associated interstitial lung disease. <em>N Engl J Med<\/em> 2019;<strong>381<\/strong>(3):291\u2013293. <\/li>","DOI":"10.1056\/NEJMc1900045"},{"key":"10.12890\/2021_002860_ref18","doi-asserted-by":"crossref","unstructured":"<li>Li T, Guo L, Chen Z, Gu L, Sun F, Tan X, et al. Pirfenidone in patients with rapidly progressive interstitial lung disease associated with clinically amyopathic dermatomyositis. <em>Sci Rep<\/em> 2016;<strong>6<\/strong>:33226. <\/li>","DOI":"10.1038\/srep33226"},{"key":"10.12890\/2021_002860_ref19","doi-asserted-by":"crossref","unstructured":"<li>Romero-Bueno F, Diaz Del Campo P, Trallero-Aragu\u00e1s E, Ruiz-Rodr\u00edguez J, Castellvi I, Rodriguez-Nieto M, et al. Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. <em>Semin Arthritis Rheum<\/em> 2020;<strong>50<\/strong>(4):776\u2013790.<\/li>","DOI":"10.1016\/j.semarthrit.2020.03.007"}],"container-title":["European Journal of Case Reports in Internal Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/2860\/2856","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/2860\/2857","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/download\/2860\/2857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T12:25:16Z","timestamp":1755865516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ejcrim.com\/index.php\/EJCRIM\/article\/view\/2860"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,18]]},"references-count":19,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.12890\/2021_002860","relation":{"has-manifestation":[{"id-type":"other","id":"1-78-2860-g2856","asserted-by":"subject"},{"id-type":"other","id":"1-78-2860-g2857","asserted-by":"subject"}],"is-part-of":[{"id-type":"other","id":"1-78","asserted-by":"subject"}]},"ISSN":["2284-2594"],"issn-type":[{"type":"electronic","value":"2284-2594"}],"subject":[],"published":{"date-parts":[[2021,10,18]]},"article-number":"7"}}